Thiopental as substitute therapy for critically ill patients with COVID-19 requiring mechanical ventilation and prolonged sedation

Med Intensiva (Engl Ed). 2022 Jan;46(1):58-61. doi: 10.1016/j.medine.2020.07.004.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Critical Illness
  • Humans
  • Respiration, Artificial
  • SARS-CoV-2
  • Thiopental*

Substances

  • Thiopental